The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Describe new and emerging systemic therapy options for patients with metastatic urothelial bladder cancer and how patient and disease characteristics can guide therapy choice.
Discuss the results of recent clinical trials for treatment of bladder cancer and their potential impact on treatment.
Review recent NCCN Guideline updates for the treatment of bladder cancer, and how they may be incorporated into clinical practice.